Clinical Trials Sponsored by Pharmenterprises Biotech LLC

Total 90 results

Pharmenterprises Biotech LLC

Completed

Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy Volunteers

Influenza A

Russian Federation
PHARMENTERPRISES LLC
EURRUS Biotech GmbH

Completed

XC8 in the Treatment of Patients With Bronchial Asthma

Bronchial Asthma

Russian Federation
PHARMENTERPRISES LLC

Not yet recruiting

Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19

SARS-CoV-2 Infection | Lung Fibrosis
PHARMENTERPRISES LLC

Completed

Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.

Healthy Volunteers

Russian Federation
PHARMENTERPRISES LLC

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers

Metabolic Syndrome
PHARMENTERPRISES LLC

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

Influenza | Acute Respiratory Infection

Russian Federation
PHARMENTERPRISES LLC

Completed

Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

SARS-CoV-2 Infection | Fibrosis Lung

Russian Federation
PHARMENTERPRISES LLC

Completed

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

Influenza | Acute Respiratory Viral Infections

Russian Federation
PHARMENTERPRISES LLC

Completed

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

Influenza | Acute Respiratory Infection

Russian Federation
PHARMENTERPRISES LLC

Completed

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

Asthma

Russian Federation
PHARMENTERPRISES LLC
RSV Therapeutics LLC

Completed

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

Influenza | Acute Respiratory Viral Infections

Russian Federation
Alpine Biotech LLC

Active, not recruiting

Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans

Obesity | Overweight and Obesity | Fat Burn | Blood Sugar; High

United States
ZZ Biotech, LLC

Completed

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers

Healthy

Austria
Mentrik Biotech, LLC

Unknown

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Previously Treated CD20+ B-cell Malignancies

United States
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Metro International Biotech, LLC

Recruiting

Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program

Healthy

United States
Metro International Biotech, LLC

Completed

Phase 2a MIB-626 vs. Placebo COVID-19

Covid19 | Stage 1 Acute Kidney Injury

United States
GY Highland Biotech LLC

Unknown

The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection

Cervical Intraepithelial Neoplasia Grade 2/3

United States
Oncolytics Biotech
PrECOG, LLC.

Active, not recruiting

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Breast Cancer Metastatic

United States
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability

COVID-19 | Sars-CoV-2 Infection

United States
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

COVID-19 | SARS-CoV2 Infection

United States
Janssen Biotech, Inc.
Pharmacyclics LLC.

Approved for marketing

An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Relapsed or Refractory Mantle Cell Lymphoma

United States, Brazil, Puerto Rico
SOTIO Biotech AG
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Castration-resistant Prostate Cancer | Cutaneous Squamous Cell Carcinoma

Italy, Spain, France, Belgium, Czechia, United States, Poland, Georgia, Hungary
Macquarie University, Australia
ZZ Biotech, LLC

Completed

3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Australia
Galecto Biotech AB
QPS Holdings LLC

Completed

A Study to Compare Pharmacokinetics of GB1211

Pharmacokinetics

Netherlands
IO Biotech
Merck Sharp & Dohme LLC

Completed

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

NSCLC

United Kingdom, Germany, Netherlands, Spain
Chemlmmune Therapeutics LLC
EURRUS Biotech GmbH

Completed

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

Eosinophilic Asthma | Bronchial Asthma

Russian Federation
Honeybrains Biotech LLC
Cognitive Research Corporation

Completed

Safety and Efficacy of HB-1 for Panic Disorder

Panic Disorder

United States
BioNTech US Inc.
Merck Sharp & Dohme LLC

Completed

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung

United States
Botec Analysis, LLC

Unknown

An Evaluation of the NJSPB SCF Project for Opioid-Involved High-Risk Parolees

Substance Abuse | Criminal Behavior

United States
ProDa BioTech, LLC
National Cancer Institute (NCI)

Recruiting

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Advanced Pancreatic Cancer | Solid Tumor Malignancies

United States
E-Star BioTech, LLC
Mayo Clinic; Integrium

Completed

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects (DTC/RHS)

Resistant Hypertension | Difficult to Control Hypertension

United States
Aduro Biotech, Inc.
Merck Sharp & Dohme LLC

Terminated

Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)

Malignant Pleural Mesothelioma

United States
Janssen Biotech, Inc.
Merck Sharp & Dohme LLC

Completed

Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

Autoimmune Diseases | Arthritis | Arthritis, Rheumatoid

United States, United Kingdom, Belgium, Greece, Canada, Germany, Sweden, Austria
E-Star BioTech, LLC
Mayo Clinic; PPD

Not yet recruiting

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Difficult to Control Hypertension
Galecto Biotech AB
Syneos Health; bioRASI, LLC

Completed

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
Aduro Biotech, Inc.
Merck Sharp & Dohme LLC

Terminated

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States
Janssen Biotech, Inc.
Merck Sharp & Dohme LLC

Completed

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

Inflammatory Bowel Disease
Evaxion Biotech A/S
Merck Sharp & Dohme LLC

Recruiting

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

Melanoma Stage IV | Melanoma Stage III

Australia
Nanjing Legend Biotech Co.
Janssen Research & Development, LLC

Recruiting

A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma (CARTIFAN-1)

Multiple Myeloma

China
Guangdong GD Kongming Biotech LLC
Jinan University Guangzhou

Withdrawn

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Advanced Hepatocellular Carcinoma

China
Haining Health-Coming Biotech Co., Ltd.
Alphacait, LLC

Unknown

Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

Metastatic Cancer

China
NanOlogy, LLC
US Biotest, Inc.

Completed

Study of Topical SOR007 Ointment for Cutaneous Metastases

Cutaneous Metastasis

United States
iOx Therapeutics
Merck Sharp & Dohme LLC

Active, not recruiting

IMM60 and Pembrolizumab in Melanoma and NSCLC

Melanoma | Non-small Cell Lung Cancer

Spain, United States, United Kingdom
Metro International Biotech, LLC
Children's Hospital of Philadelphia

Completed

NAD+ Precursor Supplementation in Friedreich's Ataxia

Friedreich Ataxia

United States
NanOlogy, LLC
US Biotest, Inc.

Available

Expanded Access to NanoPac
NanOlogy, LLC
US Biotest, Inc.

Completed

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

United States
NanOlogy, LLC
US Biotest, Inc.

Terminated

Trial of NanoPac Focal Therapy for Prostate Cancer

Urogenital Neoplasms | Genital Neoplasms, Male | Prostate Cancer | Prostate Adenocarcinoma | Prostatic Neoplasm | Localized Cancer | Prostate Cancer Adenocarcinoma

United States
NanOlogy, LLC
US Biotest, Inc.

Withdrawn

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma of Kidney | Adenocarcinoma, Renal
NanOlogy, LLC
US Biotest, Inc.

Available

Expanded Access to NanoDoce

Urogenital Neoplasms

Clinical Trials Sponsored by Pharmenterprises Biotech LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations